Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 7Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Advanced Gastric Adenocarcinoma 2Uterine Cervical Neoplasms 1Turcot syndrome 1Stomach Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Liver Neoplasms 1Liver Diseases 1Leukemia, Myeloid, Acute 1Immune Checkpoint Inhibition 1ESCC 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Bites and Stings 1Advanced Hepatocellular Carcinoma 1

Interventions

camrelizumab 2spartalizumab 1apatinib 1S 1 (combination) 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Advanced Gastric Adenocarcinoma × camrelizumab × Clear all
NCT04675866 2022-04-15

Camrelizumab Combined With Albumin-bound Paclitaxel and S-1 in the Treatment of Advanced Gastric Cancer

Henan Cancer Hospital

Phase NA Unknown
46 enrolled
Gastrointestinal

Advanced Gastric Adenocarcinoma

NCT04174339 2019-11-22

PD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric Cancer

Fujian Cancer Hospital

Phase NA Unknown
20 enrolled
Gastrointestinal

Advanced Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡